XML 58 R100.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor Information Cashflows (Details) 2 (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities $ 116,837 $ 101,400 $ 76,597
Cash flow from investing activities:      
(Loans to) repayments from affiliates 0 0 0
Capital expenditures (86,344) (127,728) (156,616)
Proceeds from Insurance Settlement, Investing Activities 1,500 0 0
Proceeds from derivative instruments 114 7,572 14,412
Payments to Acquire Businesses, Net of Cash Acquired 0 0 20,510
Other 929 194 748
Net cash used in investing activities (83,801) (119,962) (161,966)
Cash flow from financing activities:      
Loans from (repayments to) affiliates 0 0 0
Short-term debt borrowings (7,265) (5,738) 14,016
Revolving Facility borrowings 166,000 425,000 584,000
Revolving Facility reductions (171,500) (587,500) (482,000)
Proceeds from long-term debt 0 300,000 0
Principal payments on long term debt (225) (225) (222)
Supply chain financing (17,508) (2,967) 4,970
Proceeds from exercise of stock options 448 157 2,028
Purchase of treasury shares (1,825) (103,445) (30,940)
Refinancing fees and debt issuance costs (560) (6,385) (4,988)
Other (5,210) 5,215 (1,403)
Net cash provided by (used in) financing activities (37,645) 24,112 85,461
Net (decrease) increase in cash and cash equivalents (4,609) 5,550 92
Effect of exchange rate changes on cash and cash equivalents (820) (662) (759)
Cash and cash equivalents at beginning of period 17,317 12,429 13,096
Cash and cash equivalents at end of period 11,888 17,317 12,429
Parent Company [Member]
      
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities (13,718) 44,361 130,522
Cash flow from investing activities:      
(Loans to) repayments from affiliates 15,578 (66,869) 0
Capital expenditures 0 0 0
Proceeds from Insurance Settlement, Investing Activities 0    
Proceeds from derivative instruments 0 0 0
Payments to Acquire Businesses, Net of Cash Acquired     20,510
Other 0 0 0
Net cash used in investing activities (15,578) 66,869 (20,510)
Cash flow from financing activities:      
Loans from (repayments to) affiliates 0 (169,656) (79,788)
Short-term debt borrowings 0 0 0
Revolving Facility borrowings 0 0 0
Revolving Facility reductions 0 0 0
Proceeds from long-term debt   300,000  
Principal payments on long term debt 0 0 0
Supply chain financing 0 0 0
Proceeds from exercise of stock options 448 157 2,028
Purchase of treasury shares (1,825) (103,445) (30,940)
Refinancing fees and debt issuance costs (483) (5,018) 0
Other 0 104 (946)
Net cash provided by (used in) financing activities (1,860) 22,142 (109,646)
Net (decrease) increase in cash and cash equivalents 0 (366) 366
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of period 0 366 0
Cash and cash equivalents at end of period 0 0 366
Guarantor Subsidiaries [Member]
      
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities 72,111 85,973 99,596
Cash flow from investing activities:      
(Loans to) repayments from affiliates 15,000 158,985 75,459
Capital expenditures (52,278) (91,183) (100,648)
Proceeds from Insurance Settlement, Investing Activities 0    
Proceeds from derivative instruments 437 3,166 13,265
Payments to Acquire Businesses, Net of Cash Acquired     0
Other 322 0 0
Net cash used in investing activities 36,519 (70,968) (11,924)
Cash flow from financing activities:      
Loans from (repayments to) affiliates (15,578) 66,869 (152,972)
Short-term debt borrowings 6 7,493 7,510
Revolving Facility borrowings (75,000) (292,000) 444,000
Revolving Facility reductions 94,500 454,500 (382,000)
Proceeds from long-term debt   0  
Principal payments on long term debt (166) (171) (168)
Supply chain financing 0 0 0
Proceeds from exercise of stock options 0 0 0
Purchase of treasury shares 0 0 0
Refinancing fees and debt issuance costs (15) (724) (4,904)
Other 0 0 0
Net cash provided by (used in) financing activities (35,265) (156,019) (88,534)
Net (decrease) increase in cash and cash equivalents 327 922 (862)
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of period 4,425 3,503 4,365
Cash and cash equivalents at end of period 4,752 4,425 3,503
Non-Guarantor Subsidiaries [Member]
      
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities 58,444 23,066 (153,521)
Cash flow from investing activities:      
(Loans to) repayments from affiliates 0 0 152,972
Capital expenditures (34,066) (36,545) (55,968)
Proceeds from Insurance Settlement, Investing Activities (1,500)    
Proceeds from derivative instruments (323) 4,406 1,147
Payments to Acquire Businesses, Net of Cash Acquired     0
Other 607 194 748
Net cash used in investing activities 32,282 31,945 98,899
Cash flow from financing activities:      
Loans from (repayments to) affiliates (15,000) 10,671 4,329
Short-term debt borrowings 7,259 (1,755) 6,506
Revolving Facility borrowings (91,000) (133,000) 140,000
Revolving Facility reductions 77,000 133,000 (100,000)
Proceeds from long-term debt   0  
Principal payments on long term debt (59) (54) (54)
Supply chain financing (17,508) (2,967) 4,970
Proceeds from exercise of stock options 0 0 0
Purchase of treasury shares 0 0 0
Refinancing fees and debt issuance costs (62) (643) (84)
Other (5,210) 5,111 (457)
Net cash provided by (used in) financing activities (31,098) 13,873 55,210
Net (decrease) increase in cash and cash equivalents (4,936) 4,994 588
Effect of exchange rate changes on cash and cash equivalents (820) (662) (759)
Cash and cash equivalents at beginning of period 12,892 8,560 8,731
Cash and cash equivalents at end of period 7,136 12,892 8,560
Consolidating Entries and Eliminations [Member]
      
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities 0 (52,000) 0
Cash flow from investing activities:      
(Loans to) repayments from affiliates (30,578) (92,116) (228,431)
Capital expenditures 0 0 0
Proceeds from Insurance Settlement, Investing Activities 0    
Proceeds from derivative instruments 0 0 0
Payments to Acquire Businesses, Net of Cash Acquired     0
Other 0 0 0
Net cash used in investing activities 30,578 92,116 (228,431)
Cash flow from financing activities:      
Loans from (repayments to) affiliates 30,578 92,116 228,431
Short-term debt borrowings 0 0 0
Revolving Facility borrowings 0 0 0
Revolving Facility reductions 0 0 0
Proceeds from long-term debt   0  
Principal payments on long term debt 0 0 0
Supply chain financing 0 0 0
Proceeds from exercise of stock options 0 0 0
Purchase of treasury shares 0 0 0
Refinancing fees and debt issuance costs 0   0
Other 0 0 0
Net cash provided by (used in) financing activities 30,578 144,116 228,431
Net (decrease) increase in cash and cash equivalents 0 0 0
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of period 0 0 0
Cash and cash equivalents at end of period $ 0 $ 0 $ 0